knowledge -WSS

knowledge

author：fashion 2025-09-29 22:37:23 - browse：671

Alzheimer’s disease has killed at least three women in Astrida Schaeffer’s family over two generations, leaving her feeling helpless and bereft.

The first was her Polish-born maternal grandmother, who began showing symptoms when Schaeffer started college in 1981 and died seven years later. Then came her mother, a onetime Fulbright Scholar and high school language teacher who had been fluent in five languages but lost the ability to speak. She died in 2019. Last year, the disease killed Schaeffer’s mother’s sister, a former lab technician for Johnson & Johnson.

Schaeffer, a 59-year-old costume historian in North Berwick, Maine, has no symptoms of Alzheimer’s. But in 2021 her family history led her to apply to join a clinical trial testing a drug on people at risk for developing them. To participate, volunteers couldn’t have cognitive impairment. But they needed to test positive for a biomarker that put them at higher risk for mental decline ― deposits of a sticky toxic protein in the brain called beta-amyloid that is a hallmark of the disease.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： New air purifier tech could be key to improving indoor air quality
Next article： Americans' trust in science, scientist continues decline: Report

hotspot

leisure time

WSS

Chemotherapy shortages won’t get better under Biden’s latest plan

Abortion clinic in Cancun will cater to Americans

Americans' trust in science, scientist continues decline: Report

Study: New antibiotic targets gonorrhea as well as last existing drug

Patients' immediate access to test results puts radiologists in a bind

What PEPFAR has meant on the ground in Ukraine

Wikipedia

knowledge

focus

Wildfire smoke exposes gaps in outdoor worker protections

Pregnancy discrimination could be enabled by AI

Medical records are filled with copy

Sanofi says it has 12 blockbusters on the way. Will investors believe it?

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

Will General Catalyst be the first of many hospital takeovers?

New Eli Lilly Alzheimer’s data poses Medicare coverage conundrum

Pregnancy discrimination could be enabled by AI

Continuity nursing helped my family in our darkest PICU moments

Patients' immediate access to test results puts radiologists in a bind

knowledge

Pfizer plans to depart BIO

What causes an itch? Researchers may have solved the mystery

Medicare solvency divides Republicans at the presidential debate

The woman behind the Dana Farber

In diabetes hearing, Sanders takes on a new foe: food makers

Senate panel clears PBM, hopsital reforms

entertainment

hotspot

leisure time

focus